SCHEMBL1100720

SCHEMBL1100720

CCS(=O)(=O)N(CCOC)c1sc2ccccc2c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 4/20 0.44
HPGD P15428 4/20 0.44
TSHR P16473 1/20 0.44
TRPM8 Q7Z2W7 5/20 0.40
HTT P42858 2/20 0.37
NPC1 O15118 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD11B1 P28845 1/20 0.36
NR1I2 O75469 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
MAPT P10636 2/20 0.33
TUBB4A P04350 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099356 0.86 TRPM8 (0.40) ALDH1A1KDM4EHPGDTSHRTRPM8
SCHEMBL1099646 0.85 TRPM8 (0.49) ALDH1A1KDM4EHPGDTSHRTRPM8
SCHEMBL1100231 0.82 TRPM8 (0.39) ALDH1A1KDM4EHPGDTSHRTRPM8
SCHEMBL1099130 0.81 TRPM8 (0.43) ALDH1A1HPGDTSHRTRPM8NPC1
SCHEMBL1099978 0.80 TRPM8 (0.37) ALDH1A1KDM4EHPGDTSHRTRPM8
SCHEMBL1098846 0.78 TRPM8 (0.40) ALDH1A1KDM4EHPGDTSHRTRPM8
SCHEMBL1100085 0.77 TRPM8 (0.41) ALDH1A1KDM4EHPGDTSHRTRPM8
SCHEMBL1099760 0.76 TRPM8 (0.39) TRPM8HTTMAPK1SMN1; SMN2HSD11B1
SCHEMBL1100105 0.76 TRPM8 (0.43) ALDH1A1KDM4ETSHRTRPM8NPC1
SCHEMBL1099500 0.75 TRPM8 (0.41) ALDH1A1KDM4EHPGDTSHRTRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 ALDH1A1 3091/4885KDM4E 3266/4885HPGD 2923/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 ALDH1A1 3091/4885KDM4E 3266/4885HPGD 2923/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 ALDH1A1 3091/4885KDM4E 3266/4885HPGD 2923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.